Regulation of Mec1 kinase activity by the SWI/SNF chromatin remodeling complex

被引:18
|
作者
Kapoor, Prabodh [1 ]
Bao, Yunhe [1 ]
Xiao, Jing [1 ]
Luo, Jie [2 ]
Shen, Jianfeng [3 ]
Persinger, Jim [1 ]
Peng, Guang [3 ]
Ranish, Jeff [2 ]
Bartholomew, Blaine [1 ]
Shen, Xuetong [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA
[2] Inst Syst Biol, Seattle, WA 98109 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Smithville, TX 78957 USA
基金
美国国家卫生研究院;
关键词
chromatin remodeling; checkpoint regulation; Mec1; ATR; SWI/SNF; DOUBLE-STRAND BREAKS; DNA-DAMAGE CHECKPOINT; YEAST; REPAIR; ATR; TRANSCRIPTION; REPLICATION; ACTIVATION; DOMAIN; PROTEINS;
D O I
10.1101/gad.257626.114
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
ATP-dependent chromatin remodeling complexes alter chromatin structure through interactions with chromatin substrates such as DNA, histones, and nucleosomes. However, whether chromatin remodeling complexes have the ability to regulate nonchromatin substrates remains unclear. Saccharomyces cerevisiae checkpoint kinase Mec1 (ATR in mammals) is an essential master regulator of genomic integrity. Here we found that the SWI/SNF chromatin remodeling complex is capable of regulating Mec1 kinase activity. In vivo, Mec1 activity is reduced by the deletion of Snf2, the core ATPase subunit of the SWI/SNF complex. SWI/SNF interacts with Mec1, and cross-linking studies revealed that the Snf2 ATPase is the main interaction partner for Mec1. In vitro, SWI/SNF can activate Mec1 kinase activity in the absence of chromatin or known activators such as Dpb11. The subunit requirement of SWI/SNF-mediated Mec1 regulation differs from that of SWI/SNF-mediated chromatin remodeling. Functionally, SWI/SNF-mediated Mec1 regulation specifically occurs in S phase of the cell cycle. Together, these findings identify a novel regulator of Mec1 kinase activity and suggest that ATP-dependent chromatin remodeling complexes can regulate nonchromatin substrates such as a checkpoint kinase.
引用
收藏
页码:591 / 602
页数:12
相关论文
共 50 条
  • [21] Structural analysis of the yeast SWI/SNF chromatin remodeling complex
    Smith, CL
    Horowitz-Scherer, R
    Flanagan, JF
    Woodcock, CL
    Peterson, CL
    NATURE STRUCTURAL BIOLOGY, 2003, 10 (02) : 141 - 145
  • [22] SWI/SNF Chromatin Remodeling Complex: A New Cofactor in Reprogramming
    Ling He
    Huan Liu
    Liling Tang
    Stem Cell Reviews and Reports, 2012, 8 : 128 - 136
  • [23] SnapShot: Chromatin Remodeling: SWI/SNF
    Kasten, Margaret M.
    Clapier, Cedric R.
    Cairns, Bradley R.
    CELL, 2011, 144 (02)
  • [24] SWI/SNF chromatin remodeling complex regulates a non-chromatin substrate
    Kapoor, Prabodh
    Shen, Xuetong
    CELL CYCLE, 2015, 14 (15) : 2379 - 2380
  • [25] THE SWI/SNF CHROMATIN REMODELING COMPLEX: A NOVEL CONTRIBUTOR TO CANCER PROGRESSION
    Weissman, Bernard E.
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3670 - 3670
  • [26] Role of chromatin remodeling complex SWI/SNF and VDR in chronic rhinosinusitis
    Kowalik, Katarzyna
    Waniewska-Leczycka, Martyna
    Sarnowska, Elzbieta
    Rusetska, Natalia
    Sierdzinski, Janusz
    Zagor, Mariola
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (03): : 313 - 323
  • [27] Epigenetic silencing of Brahma, a subunit of the chromatin remodeling complex SWI/SNF
    Kahali, Bhaskar
    Gramling, Sarah
    Thompson, Ken
    Marquez, Stefanie
    Lu, Lu
    Reisman, David
    CANCER RESEARCH, 2013, 73
  • [28] Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits
    Phelan, ML
    Sif, S
    Narlikar, GJ
    Kingston, RE
    MOLECULAR CELL, 1999, 3 (02) : 247 - 253
  • [29] Role of SWI/SNF Chromatin Remodeling Complex in Tumor Drug Resistance
    Zhu, Gui-Zhen
    Ye, Qiao
    Luo, Yuan
    Peng, Jie
    Wang, Lu
    Yang, Zhao-Ting
    Duan, Feng-Sen
    Guo, Bing-Qian
    Mei, Zhu-Song
    Wang, Guang-Yun
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2025, 52 (01) : 20 - 31
  • [30] Genetic alterations in SWI/SNF chromatin remodeling complex in lung adenocarcinoma
    Delgado-Urena, M.
    Cuadros, M.
    Peinado, P.
    Andrades, A.
    Rodriguez, M. I.
    Garcia, D. J.
    Medina, P. P.
    Villen, J. C.
    Garcia-Villanova, P.
    Quero, F.
    Lopez-Hidalgo, J.
    Gallardo, M.
    Jurado, J. M.
    ANNALS OF ONCOLOGY, 2020, 31 : S797 - S797